8.54
price down icon0.12%   -0.01
after-market Dopo l'orario di chiusura: 8.54
loading
Precedente Chiudi:
$8.55
Aprire:
$8.55
Volume 24 ore:
755.34K
Relative Volume:
0.20
Capitalizzazione di mercato:
$354.50M
Reddito:
$324.00K
Utile/perdita netta:
$-82.10M
Rapporto P/E:
-9.1828
EPS:
-0.93
Flusso di cassa netto:
$-69.18M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+926.44%
1 anno Prestazione:
+808.80%
Intervallo 1D:
Value
$8.54
$8.55
Intervallo di 1 settimana:
Value
$8.54
$8.55
Portata 52W:
Value
$0.75
$8.55

Chimerix Inc Stock (CMRX) Company Profile

Name
Nome
Chimerix Inc
Name
Telefono
919.806.1074
Name
Indirizzo
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Name
Dipendente
81
Name
Cinguettio
@chimerix
Name
Prossima data di guadagno
2025-03-21
Name
Ultimi documenti SEC
Name
CMRX's Discussions on Twitter

Confronta CMRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CMRX
Chimerix Inc
8.54 354.50M 324.00K -82.10M -69.18M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Chimerix Inc Stock (CMRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-05-23 Iniziato Robert W. Baird Outperform
2022-09-07 Iniziato CapitalOne Overweight
2021-04-29 Iniziato Maxim Group Buy
2021-04-23 Ripresa Cowen Outperform
2021-03-31 Iniziato Jefferies Buy
2021-03-31 Iniziato Wedbush Outperform
2018-02-14 Downgrade JP Morgan Neutral → Underweight
2018-02-02 Iniziato H.C. Wainwright Buy
2016-08-09 Reiterato FBR Capital Mkt Perform
2016-02-23 Downgrade Barclays Overweight → Equal Weight
2016-02-23 Reiterato FBR Capital Mkt Perform
2016-02-23 Downgrade Morgan Stanley Equal-Weight → Underweight
2016-02-22 Downgrade Citigroup Buy → Neutral
2015-12-29 Downgrade JP Morgan Overweight → Neutral
2015-12-28 Downgrade FBR Capital Outperform → Mkt Perform
2015-12-28 Reiterato Piper Jaffray Overweight
2015-12-17 Iniziato UBS Buy
2015-10-05 Downgrade Morgan Stanley Overweight → Equal-Weight
2015-09-03 Iniziato Citigroup Buy
2015-08-18 Iniziato FBR Capital Outperform
2015-08-06 Reiterato Brean Capital Buy
2015-05-11 Reiterato Brean Capital Buy
2015-03-04 Iniziato Barclays Overweight
2015-02-12 Reiterato Stifel Buy
2014-12-31 Reiterato Brean Capital Buy
2014-07-08 Ripresa Brean Capital Buy
Mostra tutto

Chimerix Inc Borsa (CMRX) Ultime notizie

pulisher
May 28, 2025

CHIMERIX Earnings Preview: Recent $CMRX Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 28, 2025
pulisher
May 27, 2025

Northern Trust Corp Sells 36,038 Shares of Chimerix, Inc. (NASDAQ:CMRX) - Defense World

May 27, 2025
pulisher
May 26, 2025

Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Millennium Management LLC - Defense World

May 26, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Purchases Shares of 60,317 Chimerix, Inc. (NASDAQ:CMRX) - Defense World

May 19, 2025
pulisher
May 18, 2025

Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - Defense World

May 18, 2025
pulisher
May 10, 2025

StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX) - Defense World

May 10, 2025
pulisher
May 02, 2025

Halper Sadeh LLP, bluebird bio, Inc., Walgreens Boots Alliance, Chimerix, Inc. - Olean Times Herald

May 02, 2025
pulisher
May 02, 2025

Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Chimerix, Inc. to Host Earnings Call - ACCESS Newswire

Apr 30, 2025
pulisher
Apr 30, 2025

Why Chimerix Inc. (CMRX) is Surging in 2025 - Insider Monkey

Apr 30, 2025
pulisher
Apr 29, 2025

Investor Network: Chimerix, Inc. to Host Earnings Call - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 29, 2025

Geode Capital Management LLC Lowers Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World

Apr 29, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 22, 2025

Jazz Pharmaceuticals Acquires Chimerix for $935M - Contract Pharma

Apr 22, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

Chimerix Terminates Loan and Delists from Nasdaq - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ St - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix - StreetInsider

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Jazz's $935M Chimerix Buyout Targets First-Ever Treatment for Rare Brain Cancer, FDA Verdict Looms - Stock Titan

Apr 21, 2025
pulisher
Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 - Investing.com

Apr 10, 2025
pulisher
Apr 07, 2025

Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest

Apr 07, 2025
pulisher
Apr 07, 2025

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Apr 07, 2025
pulisher
Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - MSN

Apr 02, 2025
pulisher
Apr 01, 2025

Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex

Apr 01, 2025
pulisher
Mar 31, 2025

11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 31, 2025

Exploring US High Growth Tech Stocks In March 2025 - simplywall.st

Mar 31, 2025
pulisher
Mar 26, 2025

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo

Mar 26, 2025
pulisher
Mar 24, 2025

11 Best Performing Stocks So Far In 2025 - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Jazz strikes the chord with $935m Chimerix acquisition - BioXconomy

Mar 24, 2025
pulisher
Mar 24, 2025

Chimerix Reports 2024 Losses Amid Acquisition News - TipRanks

Mar 24, 2025
pulisher
Mar 21, 2025

Chimerix earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Inc Reports Q4 2024 EPS of -$0.25, Beating Estimates; R - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued - Endpoints News

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix: Q4 Earnings Snapshot - mySA

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Inc. (CMRX) reports earnings - Quartz

Mar 21, 2025

Chimerix Inc Azioni (CMRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):